University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Patient Preferences for HR+/HER2‒ Early Breast Cancer Adjuvant Treatment : A Multicountry Discrete Choice Experiment

Simple item page
dc.contributor.authorHarmer, Victoria
dc.contributor.authorAmmendolea, Cathy
dc.contributor.authorRyan, Mandy
dc.contributor.authorBoyle, Frances
dc.contributor.authorWerutsky, Gustavo
dc.contributor.authorEl Mouzain, Dina
dc.contributor.authorMarshall, Deborah A.
dc.contributor.authorThomas, Caitlin
dc.contributor.authorHeidenreich, Sebastian
dc.contributor.authorLu, Hui
dc.contributor.authorKrucien, Nicolas
dc.contributor.authorPayan, Juan Mora
dc.contributor.authorAubel, Dawn
dc.contributor.authorDanyliv, Andriy
dc.contributor.authorPathak, Purnima
dc.contributor.authorHarbeck, Nadia
dc.contributor.institutionUniversity of Aberdeen.Health Economics Research Uniten
dc.date.accessioned2025-02-03T14:53:01Z
dc.date.available2025-02-03T14:53:01Z
dc.date.issued2025-01
dc.descriptionA multicountry steering committee of 8 members – including clinicians, patient representatives, and experts on preference methods – advised on the study design and provided feedback to develop and refine the DCE. We thank the patients who participated. We also thank Harrison Clarke and Ashley Samuelson for their work on the study. Medical writing was provided by Dr. Jacqueline Janowich Wasserott (Evidera) and funded by Novartis.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent784497
dc.identifier300299826
dc.identifier594511d7-3216-47be-84e3-40b8544f7fd9
dc.identifier85218732830
dc.identifier.citationHarmer, V, Ammendolea, C, Ryan, M, Boyle, F, Werutsky, G, El Mouzain, D, Marshall, D A, Thomas, C, Heidenreich, S, Lu, H, Krucien, N, Payan, J M, Aubel, D, Danyliv, A, Pathak, P & Harbeck, N 2025, 'Patient Preferences for HR+/HER2‒ Early Breast Cancer Adjuvant Treatment : A Multicountry Discrete Choice Experiment', Breast Care, vol. 20, no. 1, pp. 16-26. https://doi.org/10.1159/000543320en
dc.identifier.doi10.1159/000543320
dc.identifier.iss1en
dc.identifier.issn1661-3791
dc.identifier.urihttps://hdl.handle.net/2164/24979
dc.identifier.vol20en
dc.language.isoeng
dc.relation.ispartofBreast Careen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectCDK4/6 inhibitoren
dc.subjectpatient preferenceen
dc.subjectdiscrete choice experimenten
dc.subjectadjuvant treatmenten
dc.subjectearly breast canceren
dc.subjectR Medicineen
dc.subjectSupplementary Informationen
dc.subjectSupplementary Dataen
dc.subjectDASen
dc.subject.lccRen
dc.titlePatient Preferences for HR+/HER2‒ Early Breast Cancer Adjuvant Treatment : A Multicountry Discrete Choice Experimenten
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Harmer_etal_BC_Patient_Preferences_HR_VOR.pdf
Size:
766.11 KB
Format:
Adobe Portable Document Format
Download

Collections

All research